Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-13 · accession 0000875320-26-000064 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-18 | 2026-02-13 | VRTX | Biller Jonathan | EVP, CLO | F - Tax | $487.76 | -2,993 | 17.8K | -14% | -$1.46M | |
| 2026-02-18 | 2026-02-13 | VRTX | Biller Jonathan | EVP, CLO | S - Sale | $499.00 | -988 | 16.8K | -6% | -$493.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-13 | F | D | 2,993 | $487.76 | 17,826 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-13 | S | D | 988 | $499.00 | 16,838 | D | — | — |